Interferon alfa-2b in renal transplant recipients with viral chronic hepatitis: A pilot study

被引：0
|
作者：
Monteon, FJ
Contreras, AM
Espinoza, L
Vazquez, G
Aguilar, S
Cueva, L
机构：
[1] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT NEPHROL,GUADALAJARA,JALISCO,MEXICO
[2] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,GUADALAJARA,JALISCO,MEXICO
[3] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,GUADALAJARA,JALISCO,MEXICO
[4] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT PATHOL,GUADALAJARA,JALISCO,MEXICO
[5] HOSP ESPECIALIDADES CTR MED LA RAZA,CTR MED OCCIDENTE,INST MEXICANO SEGURO SOCIAL,DEPT MICROBIOL,GUADALAJARA,JALISCO,MEXICO
来源：
TRANSPLANTATION PROCEEDINGS | 1996年 / 28卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3306 / 3308
页数：3
相关论文
共 50 条
  • [21] A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
    Lindsay, KL
    Trepo, C
    Heintges, T
    Shiffman, ML
    Gordon, SC
    Hoefs, JC
    Schiff, ER
    Goodman, ZD
    Laughlin, M
    Yao, RJ
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (02) : 395 - 403
  • [22] INTERFERON ALFA-2B PROLONGS LIFE, SAVES MONEY IN CHRONIC HEPATITIS-B
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (16) : 1740 - 1740
  • [23] A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C
    Glue, P
    Rouzier-Panis, R
    Raffanel, C
    Sabo, R
    Gupta, SK
    Salfi, M
    Jacobs, S
    Clement, RP
    HEPATOLOGY, 2000, 32 (03) : 647 - 653
  • [24] Interferon alfa-2b and ribavirin in patients with resistant chronic hepatitis C.
    Min, AD
    Jones, JL
    Jacobson, IM
    Klion, FM
    Goldman, IS
    Esposito, S
    Geders, JM
    Tobias, H
    Bodenheimer, HC
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
  • [25] TREATMENT WITH RECOMBINANT INTERFERON ALFA-2B IN CHILDREN WITH CHRONIC HEPATITIS-C
    HELLER, S
    CERDAN, L
    GONZALEZ, J
    VELASCO, M
    HEPATOLOGY, 1994, 19 (04) : I72 - I72
  • [26] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [27] Favorable pharmacokinetics of albumin interferon alfa-2b in subjects with chronic hepatitis C
    Fiscella, Michele
    Balan, Vijayan
    Nelson, David
    Bain, Vincent
    Zeuzem, Stefan
    McHutchison, John
    Freimuth, William
    Subramanian, Mani
    Corey, Alfred
    HEPATOLOGY, 2006, 44 (04) : 613A - 614A
  • [28] Treatment of acute hepatitis C with interferon alfa-2b
    Buffet, C
    PRESSE MEDICALE, 2002, 31 (18): : 826 - 827
  • [29] Induction therapy of interferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C genotype 1: A pilot study
    Palisoc, Alma M.
    Fayad, Joseph
    Singh, Ashok K.
    Farnham, Irene M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S164 - S164
  • [30] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
12345